Literature DB >> 19679924

[Bronchial asthma and respiratory symptoms among Icelanders 20-44 years of age.].

T Gislason, D Gislason, T Blondal.   

Abstract

OBJECTIVE: To estimate the prevalence of asthma and respiratory symptoms in an urban population. MATERIAL: Eight hundred men and women aged 20-44 years, living in the capital Reykjavik and suburbs.
METHODS: Participants answered a questionnaire, underwent skin prick testing for atopy, spirometry and a test for bronchial hyperresponsiveness (BHR) by methacholine challenge.
RESULTS: There was 77% attendance. Altogether 16.6% reported wheezing or whistling at any time in the last 12 months. Altogether 32 (5.6%)answered yes to "Have you ever had asthma?" and the diagnosis had been confirmed by a doctor in all but four. Fourteen (2.5%) had suffered from an attack of asthma in the last 12 months wheras only 0.9% were currently using anti asthmatic drugs. BHR was found among 8.7% and atopy on skin testing among 20.5%. BHR was more common among those with airflow obstruction and three times more common among the atopic participants (18% vs. 6%, p%lt;0.01). By using a history of wheezing during the last 12 months together with BHR and/or a history of doctor confirmed asthma the prevalence of current asthma was found to be 5% in our sample. The main predictive factors for asthma were a history of breathlessness and nighttime breathing symptoms, but also atopy, airflow obstruction and a maternal history of asthma.
CONCLUSION: Even by using a conservative defination, asthma is a common disorder among 20-44 years old Icelanders whereas the use of asthma medication is rather uncommon in this population.

Entities:  

Year:  1997        PMID: 19679924

Source DB:  PubMed          Journal:  Laeknabladid        ISSN: 0023-7213            Impact factor:   0.548


  1 in total

1.  Acute bronchitis and clinical outcome three years later: prospective cohort study.

Authors:  J S Jónsson; T Gíslason; D Gíslason; J A Sigurdsson
Journal:  BMJ       Date:  1998-11-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.